Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients

Fig. 2

Survival outcomes for stage I patients with molecular classification by the 31-gene expression profile test. a Recurrence-free, b distant metastasis-free, and c melanoma-specific survival rates for stage I cases (n = 264) using binary classification as indicated by Kaplan-Meier analysis. d Recurrence-free, e distant metastasis-free, and f melanoma-specific survival rates for 264 stage I cases using molecular subclassification. Five-year survival rates, number of specified events, 95% confidence intervals, and percentages of each class experiencing an event are listed in the tables below the curves

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us